EMA Recommendations on Compassionate Use of Remdesivir for COVID-19

During a virtual meeting held on April 2^nd, EMA’s human medicines committee gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease in compassionate use programs. 

To read the reccomendations, click here.